Skip to main content

Closed

PRQR: ProQR Therapeutics N.V. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-344.8%

ROIC-67.7%

Financially safe

Stretched

Debt / equity0.36×

Interest coverage0.0×

Current ratio2.48×

ProQR Therapeutics N.V.

PRQRNASDAQ Global Market·USD·Closed

ProQR Therapeutics N.V.

PRQRNASDAQ·USD·Closed

$1.72

−3.37%

$1.72

−$0.06 (3.37%)

52W Range

22thpctl

Volume

1.06×avg

Mkt Cap

181.13MUSD

P/E

-3.4TTM

Div Yield

–ann

52W Range

22thpctl

Volume

1.06×avg

Market Cap

181.13MUSD

P/E Ratio

-3.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings